These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 32745529)

  • 1. miRNAs as a novel clinical biomarker and therapeutic targets in polycystic ovary syndrome (PCOS): A review.
    Abdalla M; Deshmukh H; Atkin SL; Sathyapalan T
    Life Sci; 2020 Oct; 259():118174. PubMed ID: 32745529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of microRNA in the Pathogenesis of Polycystic Ovary Syndrome.
    Chen Z; Ou H; Wu H; Wu P; Mo Z
    DNA Cell Biol; 2019 Aug; 38(8):754-762. PubMed ID: 31305133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs related to androgen metabolism and polycystic ovary syndrome.
    Sørensen AE; Udesen PB; Wissing ML; Englund ALM; Dalgaard LT
    Chem Biol Interact; 2016 Nov; 259(Pt A):8-16. PubMed ID: 27270454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome.
    Xue Y; Lv J; Xu P; Gu L; Cao J; Xu L; Xue K; Li Q
    J Cell Biochem; 2018 May; 119(5):3913-3921. PubMed ID: 29193229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of MiRNA in polycystic ovary syndrome (PCOS).
    Chen B; Xu P; Wang J; Zhang C
    Gene; 2019 Jul; 706():91-96. PubMed ID: 31054362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of MicroRNA, Long Non-Coding RNA and Circular RNA in the Pathogenesis of Polycystic Ovary Syndrome: A Literature Review.
    Nasser JS; Altahoo N; Almosawi S; Alhermi A; Butler AE
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs Related to Polycystic Ovary Syndrome (PCOS).
    Sørensen AE; Wissing ML; Salö S; Englund AL; Dalgaard LT
    Genes (Basel); 2014 Aug; 5(3):684-708. PubMed ID: 25158044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of polycystic ovary syndrome: a practical guide.
    Stankiewicz M; Norman R
    Drugs; 2006; 66(7):903-12. PubMed ID: 16740005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
    Jeanes YM; Reeves S
    Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of microRNA profile in human cumulus granulosa cells: Identification of microRNAs that regulate Notch signaling and are associated with PCOS.
    Xu B; Zhang YW; Tong XH; Liu YS
    Mol Cell Endocrinol; 2015 Mar; 404():26-36. PubMed ID: 25622783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery.
    Rashid G; Khan NA; Elsori D; Youness RA; Hassan H; Siwan D; Seth N; Kamal MA; Rizvi S; Babker AM; Hafez W
    Arch Gynecol Obstet; 2024 May; 309(5):1707-1723. PubMed ID: 38316651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting the role of micro-RNAs as a diagnostic marker for polycystic ovary syndrome: a systematic review and meta-analysis.
    Deswal R; Dang AS
    Fertil Steril; 2020 Mar; 113(3):661-669.e2. PubMed ID: 32192599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS).
    Hadidi M; Karimabadi K; Ghanbari E; Rezakhani L; Khazaei M
    Front Endocrinol (Lausanne); 2023; 14():1269266. PubMed ID: 37964963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers.
    Long W; Zhao C; Ji C; Ding H; Cui Y; Guo X; Shen R; Liu J
    Cell Physiol Biochem; 2014; 33(5):1304-15. PubMed ID: 24802714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic aspects of polycystic ovary syndrome].
    Jakubowski L
    Endokrynol Pol; 2005; 56(3):285-93. PubMed ID: 16350721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
    Spritzer PM
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNAs: Emerging Modulators in the Pathophysiology of Polycystic Ovary Syndrome and their Clinical Implications.
    Mazloomi S; Mousavi V; Aghadavod E; Mafi A
    Curr Mol Med; 2024; 24(2):153-166. PubMed ID: 36627779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
    Escobar-Morreale HF
    Nat Rev Endocrinol; 2018 May; 14(5):270-284. PubMed ID: 29569621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially expressed microRNAs in the ovary of polycystic ovary syndrome with hyperandrogenism and insulin resistance.
    Lin L; Du T; Huang J; Huang LL; Yang DZ
    Chin Med J (Engl); 2015 Jan; 128(2):169-74. PubMed ID: 25591557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.